Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-sensitive detection of mutant <i>KRAS</i> in circulating tumor DNA predicts survival in resectable pancreatic adenocarcinoma.

Frontiers in oncology·2026
Same author

Gastrostomy Tube Placement for Enteral Nutrition Among Hospitalized Patients With Cirrhosis Is Associated With Increased Mortality.

Journal of clinical gastroenterology·2026
Same author

How Are Pregnant Patients With Irritable Bowel Syndrome or Functional Dyspepsia Managed Pharmacologically? A Cross-Sectional Study Using a Global Database.

Neurogastroenterology and motility·2026
Same author

ECOG-ACRIN E6293: Phase II Study of Raltitrexed in Advanced Colorectal Cancer.

The oncologist·2026
Same author

Paraganglioma and cardiomyopathy leading to cardiogenic shock: a case report.

ESC heart failure·2026
Same author

Management of acute withdrawal from 7-hydroxymitragynine after high-dose chronic use: A case report.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Cytotoxic T-Lymphocyte-Associated Protein 4 Deficiency Colitis Masked by Recurrent Cytomegalovirus Colitis Successfully Treated With Vedolizumab.

ACG case reports journal·2026
Same journal

Self-Inflicted Wound: Spontaneous Pancreatic Duct Stent Migration Into Hepatic Parenchyma.

ACG case reports journal·2026
Same journal

Novel Endoscopic Closure of Iatrogenic Hypopharyngeal Perforations Using Through-the-Scope Tissue Approximation Clips.

ACG case reports journal·2026
Same journal

From Case Reports to Editorial Leadership: A Roadmap for Trainee Engagement in Academic Publishing.

ACG case reports journal·2026
Same journal

Primary Hepatic Histiocytic Sarcoma Mimicking Hepatocellular Carcinoma.

ACG case reports journal·2026
Same journal

Life-Threatening Variceal Bleeding in Antisynthetase Syndrome: Nodular Regenerative Hyperplasia and Porto-Sinusoidal Vascular Disorder.

ACG case reports journal·2026
See all related articles

Related Experiment Video

Updated: Jun 2, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

An Indolent Enteropathy Accelerated by Combination Immune Checkpoint Inhibitor Therapy.

Noah Lybik1, Benjamin D Liu2, Joseph R Fuchs3

  • 1Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.

ACG Case Reports Journal
|June 1, 2026
PubMed
Summary
This summary is machine-generated.

Cancer immunotherapy can cause severe gastrointestinal issues, especially in patients with autoimmune disorders. This case highlights a fatal exacerbation of enteritis following immune checkpoint inhibitor treatment.

Area of Science:

  • Oncology
  • Immunology
  • Gastroenterology

Background:

  • Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized cancer treatment.
Keywords:
enteropathygastrointestinal bleedinggastrointestinal immune-related adverse eventsimmune checkpoint inhibitorsolmesartan

More Related Videos

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

Related Experiment Videos

Last Updated: Jun 2, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

  • Gastrointestinal immune-related adverse events (irAEs) are common complications of ICI therapy.
  • Patients with pre-existing autoimmune disorders may face heightened risks from ICIs.